Dedication 发表于 2025-3-25 06:35:04
These differences are evident during fetal lung development and are mainly related to maturity in surfactant production. The male sex disadvantage is prominently manifested in premature neonates, in whom many morbidities are skewed toward the male sex. Respiratory distress syndrome and bronchopulmo招募 发表于 2025-3-25 09:13:17
http://reply.papertrans.cn/31/3096/309524/309524_22.pngPrecursor 发表于 2025-3-25 13:41:36
http://reply.papertrans.cn/31/3096/309524/309524_23.pngdetach 发表于 2025-3-25 17:28:19
Critical Places and Emerging Health Matters: Body, Risk and Spatial Obstacles sickness and/or disability. The concept analyses the duality of both physical risk and social benefit and how they can collide in one specific place and create a bodily situation where the individual needs to act. The concept of “critical places” explores the phenomenological thought about . and ha擦掉 发表于 2025-3-25 20:41:29
http://reply.papertrans.cn/31/3096/309524/309524_25.png名次后缀 发表于 2025-3-26 01:57:20
http://reply.papertrans.cn/31/3096/309524/309524_26.png他去就结束 发表于 2025-3-26 04:45:08
Book 2021s, information systems, educational and organizational psychology, sports psychology and economics. The volume analyses how trust relationships have changed and are still changing under the influence of digitalization. In addition to presenting the current state of research, the implications for tru冷峻 发表于 2025-3-26 10:21:36
http://reply.papertrans.cn/31/3096/309524/309524_28.pngsynchronous 发表于 2025-3-26 13:01:03
Preclinical Evaluation of Lentinan in Animal Modelslentinan is worth considering as one of the most useful immunopotentiators for cancer patients, and this article concerns preclinical evaluation of lentinan in experimental and animal models for cancer immunotherapy in humans.极小 发表于 2025-3-26 18:50:25
Infektionen des Transplantierten: Art und Häufigkeit wird. Bei der akuten myeloischen Leukämie wird das stark reduzierte Rezidivrisiko und das bessere 4-Jahresüberleben mit einer höheren Frühletalität als Folge der 4mal höheren Therapie-assozierten Letalität bezahlt.